ClariVest Asset Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-37,678
| Closed | -$370K | – | 760 |
|
|
2016
Q3 | $370K | Sell |
37,678
-14,316
| -28% | -$141K | 0.01% | 421 |
|
|
2016
Q2 | $294K | Buy |
51,994
+11,661
| +29% | +$65.9K | 0.01% | 430 |
|
|
2016
Q1 | $308K | Buy |
40,333
+23,366
| +138% | +$178K | 0.01% | 412 |
|
|
2015
Q4 | $226K | Buy |
16,967
+2,767
| +19% | +$36.9K | 0.01% | 444 |
|
|
2015
Q3 | $234K | Buy |
14,200
+83
| +0.6% | +$1.37K | 0.01% | 404 |
|
|
2015
Q2 | $316K | Buy |
+14,117
| New | +$316K | 0.01% | 371 |
|